EDEN PRAIRIE, Minn. & REHOVOT, Israel, January 14, 2025–Stratasys (NASDAQ: SSYS) has declared that its TrueDent-D™ resin is available for sale in Europe as a CE Mark Class I medical device. This milestone enables the sale of its TrueDent™ monolithic multi-shade digital denture solution in European countries that require CE marking.
EDEN PRAIRIE, Minn. & REHOVOT, Israel, January 14, 2025–Stratasys (NASDAQ: SSYS) has declared that its TrueDent-D™ resin is available for sale in Europe as a CE Mark Class I medical device. This milestone enables the sale of its TrueDent™ monolithic multi-shade digital denture solution in European countries that require CE marking.
